STOCK TITAN
  1. Home
  2. Sec-filings
  3. UHS
  4. [Form 4] UNIVERSAL HEALTH SERVICES INC Insider Trading Activity

UHS (UHS) director exercises 2,500 options, sells 674 Class B shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Universal Health Services director Elliot J. Sussman exercised stock options and made related share dispositions in March. He exercised options for a total of 2,500 shares of Class B Common Stock at an exercise price of $138.80 per share on March 11 and March 13.

To cover obligations tied to these exercises, 1,826 shares were delivered back to the company as tax-withholding dispositions. Sussman also sold 674 shares of Class B Common Stock in open-market transactions at weighted average prices within ranges of $186.28–$186.365 and $193.35–$193.40, according to the price ranges disclosed.

After these option exercises, tax withholdings and sales, Sussman directly holds 6,113 shares of Universal Health Services Class B Common Stock, and no remaining derivative option position from the reported grants is shown in this filing.

Positive

  • None.

Negative

  • None.
Insider SUSSMAN ELLIOT J MD MBA
Role Director
Sold 674 shs ($128K)
Type Security Shares Price Value
Exercise Option To Purchase Class B Common Stock 1,250 $0.00 --
Exercise Class B Common Stock 1,250 $138.80 $174K
Tax Withholding Class B Common Stock 894 $194.27 $174K
Sale Class B Common Stock 356 $193.3742 $69K
Exercise Option To Purchase Class B Common Stock 1,250 $0.00 --
Exercise Class B Common Stock 1,250 $138.80 $174K
Tax Withholding Class B Common Stock 932 $186.28 $174K
Sale Class B Common Stock 318 $186.3455 $59K
Holdings After Transaction: Option To Purchase Class B Common Stock — 0 shares (Direct); Class B Common Stock — 7,363 shares (Direct)
Footnotes (1)
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $186.28 to $186.365, inclusive. The reporting person undertakes to provide Universal Health Services, Inc. (the "Company"), any stockholder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnote 1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $193.35 to $193.40, inclusive. The reporting person undertakes to provide Universal Health Services, Inc. (the "Company"), any stockholder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnote 2. Option vested ratably on each of 3/17/2022, 3/17/2023, 3/17/2024 and 3/17/2025.
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
SUSSMAN ELLIOT J MD MBA
(Last) (First) (Middle)
2365 BAYPOINT WAY
(Street)
THE VILLAGES FL 32162
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
UNIVERSAL HEALTH SERVICES INC [ UHS ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
03/11/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Class B Common Stock 03/11/2026 M 1,250 A $138.8 7,363 D
Class B Common Stock 03/11/2026 F 932 D $186.28 6,431 D
Class B Common Stock 03/11/2026 S(1) 318 D $186.3455 6,113 D
Class B Common Stock 03/13/2026 M 1,250 A $138.8 7,363 D
Class B Common Stock 03/13/2026 F 894 D $194.27 6,469 D
Class B Common Stock 03/13/2026 S(2) 356 D $193.3742 6,113 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Option To Purchase Class B Common Stock $138.8 03/11/2026 M 1,250 (3) 03/16/2026 Class B Common Stock 1,250 $0 1,250 D
Option To Purchase Class B Common Stock $138.8 03/13/2026 M 1,250 (3) 03/16/2026 Class B Common Stock 1,250 $0 0 D
Explanation of Responses:
1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $186.28 to $186.365, inclusive. The reporting person undertakes to provide Universal Health Services, Inc. (the "Company"), any stockholder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnote 1.
2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $193.35 to $193.40, inclusive. The reporting person undertakes to provide Universal Health Services, Inc. (the "Company"), any stockholder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnote 2.
3. Option vested ratably on each of 3/17/2022, 3/17/2023, 3/17/2024 and 3/17/2025.
/s/ Elliot J. Sussman, M.D. 03/13/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What insider transactions did UHS director Elliot J. Sussman report?

Elliot J. Sussman reported exercising options for 2,500 UHS Class B shares, with related tax-withholding dispositions and open-market sales totaling 674 shares. These actions reflect option exercises tied to previously granted equity awards, not new open-market purchases.

How many Universal Health Services (UHS) shares did Sussman sell in the market?

Sussman sold 674 shares of UHS Class B Common Stock in open-market transactions. The sales occurred on March 11 and March 13 at weighted average prices within disclosed ranges around the mid‑$180s and low‑$190s per share.

How many UHS options did Elliot J. Sussman exercise and at what price?

He exercised options covering 2,500 shares of UHS Class B Common Stock at an exercise price of $138.80 per share. These option exercises converted derivative awards into common shares as part of his compensation-related equity holdings.

What portion of Sussman’s UHS shares were used for tax withholding?

Following the option exercises, 1,826 UHS Class B shares were delivered to satisfy exercise price or tax liabilities. These F‑code transactions are tax-withholding dispositions, meaning the shares were not sold in the open market but used to cover obligations.

How many UHS shares does Elliot J. Sussman hold after these transactions?

After completing the option exercises, tax withholdings and open-market sales, Sussman directly holds 6,113 shares of Universal Health Services Class B Common Stock. This figure reflects his updated direct equity position as reported in the filing.

Were Sussman’s UHS transactions mainly option exercises or open-market trades?

The activity centered on exercising options for 2,500 UHS shares, with subsequent tax-withholding dispositions and a smaller open-market sale of 674 shares. The pattern reflects option exercise-and-sell activity rather than large standalone market purchases or sales.